Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Everpure gains amid report activist Jana has taken a stake (SeekingAlpha) +++ EVERPURE Aktie +3,79%

EMBECTA Aktie

 >EMBECTA Aktienkurs 
2.857 EUR    -1.2%    (TradegateBSX)
Ask: 2.867 EUR / 7000 Stück
Bid: 2.831 EUR / 4800 Stück
Tagesumsatz: 208 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
EMBECTA Aktie über LYNX handeln
>EMBECTA Performance
1 Woche: +8,2%
1 Monat: -0,9%
3 Monate: -62,7%
6 Monate: -71,7%
1 Jahr: -64,7%
laufendes Jahr: -71,7%
>EMBECTA Aktie
Name:  EMBECTA CORP. DL-,01
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US29082K1051 / A3DGNE
Symbol/ Ticker:  JX7 (Frankfurt) / EMBC (NASDAQ)
Kürzel:  FRA:JX7, ETR:JX7, JX7:GR, NASDAQ:EMBC
Index:  -
Webseite:  https://www.embecta.com/
Profil:  Embecta Corporation is a dynamic player in the healthcare industry, primarily focused on producing advanced medical devices. Its chief function is to innovate and manufacture devices related to diabetes care, addressing both individual and clinical n..
>Volltext..
Marktkapitalisierung:  181.88 Mio. EUR
Unternehmenswert:  1201.22 Mio. EUR
Umsatz:  915.76 Mio. EUR
EBITDA:  319.48 Mio. EUR
Nettogewinn:  98.3 Mio. EUR
Gewinn je Aktie:  1.68 EUR
Schulden:  1205.64 Mio. EUR
Liquide Mittel:  169.89 Mio. EUR
Operativer Cashflow:  187.54 Mio. EUR
Bargeldquote:  0.78
Umsatzwachstum:  -9.57%
Gewinnwachstum:  98.45%
Dividende je Aktie:  0.39 EUR
Dividendenrendite:  14.79%
Dividendenschätzung:  15.3%
Div. Historie:  28.05.26 - 0.008576999€
27.02.26 - 0.12693€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  EMBECTA
Letzte Datenerhebung:  30.06.26
>EMBECTA Kennzahlen
Aktien/ Unternehmen:
Aktien: 59.33 Mio. St.
Frei handelbar: 92.15%
Rückkaufquote: -
Mitarbeiter: 1850
Umsatz/Mitarb.: 0.51 Mio. EUR
Analysten:
Analystenrating: Neutral
Kursziel: 25.04%
Bewertung:
KGV: 1.67
KGV lG: 1.96
KUV: 0.19
KBV: -
PEG-Ratio: 0.02
EV/EBITDA: 3.76
Rentabilität:
Bruttomarge: 62.52%
Gewinnmarge: 10.73%
Operative Marge: 29.78%
Managementeffizenz:
Gesamtkaprendite: 10.41%
Eigenkaprendite: -
>EMBECTA Peer Group
Gesundheit, Medizinprodukte & -technik/ Implantate/ Wundpflege, Stoffwechselerkrankungen (Diabetes/ Adipositas)
 
30.06.26 - 18:03
Embecta Corp. (EMBC) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit (PR Newswire)
 
BENSALEM, Pa., June 30, 2026 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Embecta Corp. ("Embecta" or the "Company") (NASDAQ: EMBC). IF YOU ARE AN INVESTOR WHO......
30.06.26 - 12:18
$EMBC Notification: Embecta Accused of Misrepresentations about its Insulin Pen Issues in Securities Fraud Class Action (PR Newswire)
 
A securities fraud class action lawsuit has been filed on behalf of Embecta investors after its stock plummeted over 57% because Embecta allegedly misled investors regarding the strength of its insulin pen needle product category. NEW YORK, June 30, 2026 /PRNewswire/ -- Leading securities......
30.06.26 - 02:36
EMBC Investors Have Opportunity to Lead Embecta Corp. Securities Fraud Lawsuit (PR Newswire)
 
NEW YORK, June 29, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Embecta Corp. (NASDAQ: EMBC) between November 25, 2025 and May 4, 2026, inclusive (the "Class Period"). A class......
29.06.26 - 21:27
Embecta Corp. (EMBC) Faces Securities Class Action for Allegedly Concealing Competitive Threats to Pen Needle Business -- HBSS (PR Newswire)
 
SAN FRANCISCO, June 29, 2026 /PRNewswire/ -- Embecta Corp. (NASDAQ: EMBC) faces a securities class action lawsuit, which seeks to represent investors who purchased or acquired Embecta common stock between November 25, 2025 and May 4, 2026. The lawsuit follows the company's disastrous Q2......
29.06.26 - 11:00
Embecta Corp. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - EMBC (PR Newswire)
 
LOS ANGELES, June 29, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Embecta Corp. ("Embecta" or "the Company") (NASDAQ: EMBC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by......
29.06.26 - 09:54
EMBC Investors Have Opportunity to Lead Embecta Corp. Securities Fraud Lawsuit with the Schall Law Firm (PR Newswire)
 
LOS ANGELES, June 29, 2026 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Embecta Corp. ("Embecta" or "the Company") (NASDAQ: EMBC) for violations of §§10(b) and 20(a) of the Securities Exchange Act......
26.06.26 - 02:12
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Embecta Corp. of Class Action Lawsuit and Upcoming Deadlines - EMBC (PR Newswire)
 
NEW YORK, June 25, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Embecta Corp. ("Embecta" or the "Company") (NASDAQ: EMBC).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW),......
25.06.26 - 11:27
EMBC Investors Have Opportunity to Lead Embecta Corp. Securities Fraud Lawsuit with the Schall Law Firm (PR Newswire)
 
LOS ANGELES, June 25, 2026 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Embecta Corp. ("Embecta" or "the Company") (NASDAQ: EMBC) for violations of §§10(b) and 20(a) of the Securities Exchange Act......
25.06.26 - 11:24
Embecta Corp. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - EMBC (PR Newswire)
 
LOS ANGELES, June 25, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Embecta Corp. ("Embecta" or "the Company") (NASDAQ: EMBC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by......
24.06.26 - 16:09
EMBC UPCOMING DEADLINE: Levi & Korsinsky Alerts Embecta Corp. Stockholders of Securities Class Action - Contact the Firm (PR Newswire)
 
Time-Sensitive: Allegations Focus on Concealed U.S. Pen Needle Share Loss at a Single Customer That Drove Embecta's 57.8% Stock Collapse NEW YORK, June 24, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP alerts investors in Embecta Corp. (NASDAQ: EMBC) of a pending securities class action.......
23.06.26 - 22:12
EMBC Investors Have Opportunity to Lead Embecta Corp. Securities Fraud Lawsuit (PR Newswire)
 
NEW YORK, June 23, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Embecta Corp. (NASDAQ: EMBC) between November 25, 2025 and May 4, 2026, inclusive (the "Class Period"). A class......
23.06.26 - 17:54
Embecta Corp. (EMBC) Faces Securities Class Action for Allegedly Concealing Competitive Threats to Pen Needle Business -- HBSS (PR Newswire)
 
SAN FRANCISCO, June 23, 2026 /PRNewswire/ -- Embecta Corp. (NASDAQ: EMBC) faces a securities class action lawsuit, which seeks to represent investors who purchased or acquired Embecta common stock between November 25, 2025 and May 4, 2026. The lawsuit follows the company's disastrous Q2......
23.06.26 - 16:06
EMBC UPCOMING DEADLINE: The Gross Law Firm Alerts Embecta Corp. Stockholders of Securities Class Action - Contact the Firm (PR Newswire)
 
NEW YORK, June 23, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Embecta Corp. (NASDAQ: EMBC). Shareholders who purchased shares of EMBC during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.......
22.06.26 - 23:54
EMBC Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Securities Class Action Lawsuit Against Embecta Corp. (PR Newswire)
 
SAN DIEGO, June 22, 2026 /PRNewswire/ -- Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Embecta Corp. (NASDAQ: EMBC) securities between November 25, 2025 and May 4, 2026. Embecta Corp., is a medical device......
22.06.26 - 18:03
Bronstein, Gewirtz & Grossman LLC Urges Embecta Corp. Investors to Act: Class Action Filed Alleging Investor Harm (PR Newswire)
 
NEW YORK, June 22, 2026 /PRNewswire/ -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Embecta Corp. (NASDAQ: EMBC) and certain of its officers. This lawsuit seeks to recover damages......
18.06.26 - 23:21
EMBC Investors Have Opportunity to Lead Embecta Corp. Securities Fraud Lawsuit (PR Newswire)
 
NEW YORK, June 18, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Embecta Corp. (NASDAQ: EMBC) between November 25, 2025 and May 4, 2026, inclusive (the "Class Period"). A class......
16.06.26 - 12:33
embecta appoints Nimish Muzumdar as SVP and President, North America (GlobeNewswire EN)
 
embecta announced that Nimish Muzumdar has been named the company's Senior Vice President and President, North America, effective June 15, 2026....
01.06.26 - 23:03
embecta to Participate in Investor Events (GlobeNewswire EN)
 
PARSIPPANY, N.J., June 01, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today announced that management will participate in the following investor events:...
20.05.26 - 15:01
Embecta Corp. (EMBC) Securities Fraud Investigation - Levi & Korsinsky (PR Newswire)
 
Embecta's Q2 FY2026 revenue and EPS fell short of both company guidance and Wall Street consensus -- shares dropped more than 25% in a single session. NEW YORK, May 20, 2026 /PRNewswire/ -- Investors who held Embecta Corp. (NASDAQ: EMBC) shares lost more than 25% of their value when the......
15.05.26 - 15:03
embecta Completes Acquisition of Owen Mumford Holdings Limited (GlobeNewswire EN)
 
PARSIPPANY, N.J., May 15, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global leader in diabetes care technology, today announced that it has completed its previously announced transaction to acquire Owen Mumford Holdings Limited (“Owen Mumford”), a privately held, UK-based innovator and manufacturer of medical devices and drug delivery technologies....
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Gott kann nichts logisch Unmögliches tun, doch setzt dies seiner Allmacht keine Grenzen. Er kann nichts Absurdes tun oder erfinden. - Leszek Kolakowski
>Aktien | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!